Erythra-Derm
Brand names,
Erythra-Derm
Analogs
Erythra-Derm
Brand Names Mixture
Erythra-Derm
Chemical_Formula
C9H13NO2
Erythra-Derm
RX_link
No information avaliable
Erythra-Derm
fda sheet
Erythra-Derm
msds (material safety sheet)
Erythra-Derm
Synthesis Reference
No information avaliable
Erythra-Derm
Molecular Weight
167.205 g/mol
Erythra-Derm
Melting Point
96 oC
Erythra-Derm
H2O Solubility
2500 mg/L
Erythra-Derm
State
Solid
Erythra-Derm
LogP
1.514
Erythra-Derm
Dosage Forms
No information avaliable
Erythra-Derm
Indication
Used for the short-term treatment of insomnia, however, it generally has been replaced by other sedative-hypnotic agents.
Erythra-Derm
Pharmacology
Ethinamate is used to treat insomnia (trouble in sleeping). However, it has generally been replaced by other medicines for the treatment of insomnia. If ethinamate is used regularly (for example, every day) to help produce sleep, it is usually not effective for more than 7 days. Structurally, it does not resemble the barbiturates, but it shares many effects with this class of drugs; the depressant effects of ethinamate are, however, generally milder than those of most barbiturates. Continued and inappropriate use of ethinamate can lead to tolerance and physical dependence, with withdrawal symptoms very similar to those of the barbiturates.
Erythra-Derm
Absorption
Rapidly absorbed following oral administration.
Erythra-Derm
side effects and Toxicity
Symptoms of overdose include shortness of breath or slow or troubled breathing, slow heartbeat, severe weakness, chronic confusion, slurred speech, and staggering.
Erythra-Derm
Patient Information
Erythra-Derm
Organisms Affected
Humans and other mammals